( OTC-BB:CDXC )

News from ChromaDex Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 05, 2014, 08:30 ET ChromaDex® CEO to Present at 34th Annual Canaccord Genuity Growth Conference on August 13th at 8:30 am EDT

 ChromaDex® Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions...


Jul 08, 2014, 08:20 ET Nobel Laureate Roger Kornberg to Chair New ChromaDex Scientific Advisory Board

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based...


Jun 03, 2014, 06:30 ET ChromaDex Licenses Exclusive Patent Rights from Dartmouth College for Pharmaceutical Use of Nicotinamide Riboside (NR)

 ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the...


May 30, 2014, 20:03 ET ChromaDex CEO to Present at the Jefferies 2014 Global Healthcare Conference

 ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to...


May 14, 2014, 08:25 ET ChromaDex® CEO to Present at 15th Annual B. Riley Conference on May 19th at 9:30 am PDT / 12:30 pm EDT

 ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to...


Jan 06, 2014, 08:30 ET ChromaDex® Announces $62 Million Ingredient Agreement with Network Marketing Company 5LINX®

 ChromaDex Corporation® (OTCBB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based...


Nov 22, 2013, 08:30 ET ChromaDex® Updates Research Activity Agreements For Its NIAGEN™ Nicotinamide Riboside

 ChromaDex Corporation® (OTCBB: CDXC) ("ChromaDex" or the "Company"), an innovative natural products company that provides proprietary,...


Nov 21, 2013, 17:50 ET ChromaDex® Reports Results for the Third Quarter 2013

 ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex" or the "Company"), an innovative natural products company that provides proprietary,...


Aug 13, 2013, 08:20 ET ChromaDex® Reports Results for the Second Quarter 2013

 ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex" or the "Company"), an innovative natural products company that provides...


Aug 05, 2013, 08:20 ET ChromaDex® Acquires New Exclusive Worldwide Patent Rights for pTeroPure® Pterostilbene Relating to Skin Care

 ChromaDex Corporation® (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and...


Jul 29, 2013, 08:20 ET ChromaDex® Enters into Agreement with Beckman Research Institute of City of Hope to Supply pTeroPure™ Pterostilbene for Cancer Research

ChromaDex Corporation® (OTCQB: CDXC) ("ChromaDex" or the "Company"), an innovative natural products company that provides proprietary,...


May 10, 2013, 06:30 ET ChromaDex® Reports Results for the First Quarter 2013

ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex" or the "Company"), an innovative natural products company that provides proprietary,...


Apr 18, 2013, 05:30 ET ChromaDex® Initiates First Human Clinical Study for Its New Caffeine Ingredient Technology, PURENERGY™

 ChromaDex Corporation® (OTCQB: CDXC) ("ChromaDex" or the "Company"), an innovative natural products company that provides proprietary,...


Apr 01, 2013, 05:30 ET ChromaDex® Introduces New Caffeine Ingredient Technology, PURENERGY™

ChromaDex Corporation® (OTCQB: CDXC) ("ChromaDex" or the "Company"), an innovative natural products company that provides proprietary,...


Mar 29, 2013, 12:30 ET ChromaDex® Reports 2012 Full-Year Results and Closes Strategic Sale of Its BluScience™ Consumer Product Line

 ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex" or the "Company"), an innovative natural products company that provides proprietary,...


Mar 21, 2013, 05:30 ET Dr. Nancy Booth of Spherix Consulting - a Division of ChromaDex® - Appointed to American Botanical Council Advisory Board

 Spherix Consulting, a division of ChromaDex® Corporation (OTCQB:CDXC) ("ChromaDex"), announced today that its Senior Science Director,...


Mar 13, 2013, 05:30 ET ChromaDex® to Present at 25th Annual ROTH Conference on March 19, 2013

 ChromaDex Corporation® (OTCQB: CDXC) ("ChromaDex"), an innovative natural products company that provides proprietary, science-based...


Mar 08, 2013, 06:35 ET ChromaDex® Adds to Its Exclusive Worldwide Patent Rights for Nicotinamide Riboside (NR) with Washington University Agreement

ChromaDex Corporation® (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and...


Feb 25, 2013, 05:30 ET ChromaDex® Plans Strategic Sale of its BluScience™ Consumer Product Line to NeutriSci International

ChromaDex Corporation® (OTCBB: CDXC) ("ChromaDex"), an innovative natural products company that provides proprietary, science-based solutions...


Feb 07, 2013, 05:30 ET ChromaDex® to Distribute LoGiCal®, a New Range of Reference Standards in the United States

 ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex") and LGC Standards announced today that they have signed an agreement for ChromaDex to...


Dec 04, 2012, 05:30 ET ChromaDex® to Present at the RedChip Small-Cap Virtual Conference on December 5th at 2:45 p.m. EST

ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex") an innovative natural products company that provides proprietary, science-based solutions...


Nov 08, 2012, 08:40 ET ChromaDex® Reports Financial Results for the Third Quarter 2012

 ChromaDex® Corporation (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and...


Oct 29, 2012, 05:30 ET ChromaDex® Announces the Award of Two Method Validation Study Contracts from the Office of Dietary Supplements, National Institutes of Health

ChromaDex® Corporation (CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to...


Sep 20, 2012, 13:49 ET Clinical Study Showed a Blueberry Antioxidant, pTeroPure® (pterostilbene), Significantly Reduced Blood Pressure in Adults

 ChromaDex® Corporation (OTCBB: CDXC) announced today findings from a Phase 2/3 trial at the University of Mississippi Medical Center...


Aug 09, 2012, 06:35 ET Human Clinical Efficacy Data for ChromaDex®'s Patented pTeroPure® (pterostilbene) to be Presented at American Heart Association's High Blood Pressure Research 2012 Scientific Sessions

 ChromaDex® Corporation (OTCBB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and...